Osteopontin predicts clinical outcome in patients after treatment of severe aortic stenosis with transcatheter aortic valve implantation (TAVI)

Abstract

OPN levels at baseline are associated with adverse outcomes in patients with severe, symptomatic AS undergoing TAVI.